[Skip to Content]
[Skip to Content Landing]

What’s Next in PrEP?: New Strategies for Prevention

Just over 10 years ago, the first agent for HIV pre-exposure prophylaxis was approved in the United States. Since then, the landscape of PrEP has shifted, with approval of additional PrEP medications and growth of low-threshold PrEP delivery strategies, such as same-day PrEP. In this interactive webinar, participants will learn about new medications in the pipeline for PrEP and emerging PrEP delivery models.

Learn now
Close
Close

Name Your Search

Save Search
Close
Close

Lookup An Activity

or

My Saved Searches

You currently have no searches saved.

Close

My Saved Courses

You currently have no courses saved.

Close